newsfilter
← Latest News
PR Newswire·

BrainStorm Issues 2024 Letter to Shareholders

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a...